**Background:** The Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel coronavirus causing severe acute respiratory infections associated with high mortality. In the present study we assessed the ability of MERS-CoV to replicate and induce innate immunity in human monocyte-derived macrophages and dendritic cells (DCs) and compared these responses to those of severe acute respiratory syndrome coronavirus (SARS-CoV).

**Methods:** Human monocyte-derived macrophages and DCs as well as A549, Calu-3 and Vero E6 cells were infected with MERS-CoV and SARS-CoV at MOI 1. Viral replication and cytokine production were measured by endpoint dilution assay, qRT-PCR and Western blot.

**Results:** Assessments of viral RNA levels by quantitative reverse transcription polymerase chain reaction (qRT-PCR) from infected cells during a 48 h infection indicated that like SARS-CoV, MERS-CoV can infect macrophages and DCs, but both viruses showed an impaired ability to replicate in these cells. This observation was supported by Western blot analysis of cell lysates showing no increase in viral N protein amounts during infection. qRT-PCR analysis of cytokine and MxA mRNA levels showed that MERS-CoV infection results in some induction of interferon lambda 1, CXCL10 and MxA mRNAs in both macrophages and DCs, whereas almost no such induction was observed by SARS-CoV. However, both viruses replicated very well in human lung epithelial Calu-3 cells followed by strong induction of interferon lambda 1, CXCL10 and MxA mRNAs.

**Conclusions:** Our data suggest that SARS-CoV and MERS-CoV replicate extremely poorly in human macrophages and DCs and thus the viruses are incapable of inducing a strong host innate immune response. However, we observed a clear difference between MERS-CoV and SARS-CoV in their ability to activate host innate immune responses in human macrophages and DCs, which may contribute to the pathogenesis of infection. This work was funded by the Sigrid Juselius Foundation and the Academy of Finland.
